Eton Pharmaceuticals (ETON) Return on Capital Employed: 2019-2025
Historic Return on Capital Employed for Eton Pharmaceuticals (ETON) over the last 6 years, with Sep 2025 value amounting to -0.05%.
- Eton Pharmaceuticals' Return on Capital Employed rose 32.00% to -0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.05%, marking a year-over-year increase of 32.00%. This contributed to the annual value of -0.08% for FY2024, which is 2.00% up from last year.
- Eton Pharmaceuticals' Return on Capital Employed amounted to -0.05% in Q3 2025, which was down 205.76% from -0.01% recorded in Q2 2025.
- Over the past 5 years, Eton Pharmaceuticals' Return on Capital Employed peaked at 0.09% during Q3 2023, and registered a low of -0.57% during Q2 2022.
- Over the past 3 years, Eton Pharmaceuticals' median Return on Capital Employed value was -0.05% (recorded in 2025), while the average stood at -0.12%.
- In the last 5 years, Eton Pharmaceuticals' Return on Capital Employed skyrocketed by 184bps in 2021 and then tumbled by 46bps in 2024.
- Quarterly analysis of 5 years shows Eton Pharmaceuticals' Return on Capital Employed stood at -0.07% in 2021, then plummeted by 42bps to -0.49% in 2022, then skyrocketed by 41bps to -0.08% in 2023, then climbed by 1bps to -0.07% in 2024, then skyrocketed by 32bps to -0.05% in 2025.
- Its Return on Capital Employed stands at -0.05% for Q3 2025, versus -0.01% for Q2 2025 and -0.04% for Q1 2025.